These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21864613)

  • 1. Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults.
    Lee S; Park WB; Shin KH; Ahn DH; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Vaccine; 2011 Oct; 29(44):7638-43. PubMed ID: 21864613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of a single intramuscular dose of a tetanus-diphtheria toxoid (Td) vaccine (BR-TD-1001) in healthy Korean adult subjects.
    Hong T; Chung YJ; Kim TY; Kim IH; Choe YK; Lee J; Jeon S; Han S; Yim DS
    Hum Vaccin Immunother; 2015; 11(10):2440-5. PubMed ID: 26091286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immunogenicity and safety of the new tetanus-reduced diphtheria (Td) vaccines (GC1107) in healthy Korean adolescents: a phase II, double-blind, randomized, multicenter clinical trial.
    Rhim JW; Lee KY; Kim SY; Kim JH; Kim HH; Kim HM; Choi YY; Ma SH; Kim DH; Ahn DH; Kang JH
    J Korean Med Sci; 2013 Apr; 28(4):586-92. PubMed ID: 23579367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of the new reduced-dose tetanus-diphtheria vaccine in healthy Korean adolescents: A comparative active control, double-blind, randomized, multicenter phase III study.
    Han SB; Rhim JW; Shin HJ; Kim SY; Kim JH; Kim HH; Lee KY; Kim HM; Choi YY; Ma SH; Kim CS; Kim DH; Ahn DH; Kang JH
    J Microbiol Immunol Infect; 2017 Apr; 50(2):207-213. PubMed ID: 26055693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.
    Lee J; Choi JH; Wie SH; Park SH; Choi SM; Lee MS; Kim TH; Lee HJ; Kang JH
    J Korean Med Sci; 2019 Jan; 34(4):e31. PubMed ID: 30686952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and Safety of a Newly Developed Tetanus-Diphtheria Toxoid (Td) in Healthy Korean Adolescents: a Multi-center, Randomized, Double-blind, Active-Controlled Phase 3 Trial.
    Choi UY; Kim KH; Lee J; Eun BW; Kim HM; Lee KY; Kim DH; Ma SH; Lee J; Kim JH
    J Korean Med Sci; 2021 Dec; 36(49):e313. PubMed ID: 34931494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of single dose of tetanus-diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007.
    Bitragunta S; Murhekar MV; Chakravarti A; Verma V; Namjoshi GS; Parekh SS; Sharma HJ; Kumar BK; Gupte MD
    Vaccine; 2010 Aug; 28(37):5934-8. PubMed ID: 20620169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization.
    Li G; Zhang H; Zhou W; Ye Q; Li F; Wang H; Hou Q; Xu Y; Ma X; Tan Y; Wang L; Li Y; Li H; Meng F; Liang Q; Liu A; Qin C; Wei W; Liu J; Ruan C; Tao W; Zhang S; Zheng H; Zhu F
    Vaccine; 2010 Jun; 28(25):4215-23. PubMed ID: 20399240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults].
    Gil A; Dal-Ré R; González A; Lasheras L; Aguilar L; del Rey J
    Med Clin (Barc); 1995 Feb; 104(4):126-9. PubMed ID: 7898155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of diphtheria-tetanus vaccine in pre-adolescent and adolescent South Koreans.
    Lee SY; Kwak GY; Nam CH; Kim JH; Hur JK; Lee KY; Park JS; Kim HM; Kang JH
    Vaccine; 2009 May; 27(24):3209-12. PubMed ID: 19446193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults.
    Chan SH; Tan PT; Han HH; Bock HL
    Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
    Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
    Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
    Palazzi DL; Rench MA; Edwards MS; Baker CJ
    J Infect Dis; 2004 Aug; 190(3):558-64. PubMed ID: 15243932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of a new equine tetanus immunoglobulin associated with tetanus-diphtheria vaccine.
    Lang J; Kamga-Fotso L; Peyrieux JC; Blondeau C; Lutsch C; Forrat R
    Am J Trop Med Hyg; 2000; 63(5-6):298-305. PubMed ID: 11421382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of diphtheria-tetanus vaccine in adults.
    Choi JH; Choo EJ; Huh A; Choi SM; Eom JS; Lee JS; Park SH; Kang JH
    J Korean Med Sci; 2010 Dec; 25(12):1727-32. PubMed ID: 21165286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.